Acciones NH TherAguix SAS

Acciones

Mercado cerrado - Euronext Paris Otros sitios de cotización 02:34:17 22/10/2021			Varia. Cinco días.	Varia. 1 de enero.
0,01 ^EUR	-.--%		-.--%	-.--%

Duración

Período

Estilo

NH TherAguix SAS : announces the publication of promising preclinical results of AGuIX® in combination with targeted radioligand therapies (TRT)	19/12
NH TherAguix SAS : appoints Vincent Carrère as Chief Executive Officer	12/09/23
NH TherAguix SAS : announces communications to be presented at the AAPM meeting by Harvard Medical Schools collaborators	21/07/23
NH TherAguix SAS : announces the arrival of Aurélien Meyzaud as Head of Intellectual Property and Business Intelligence	13/01/23
NH TherAguix SAS : announces the thesis defense of Dr. Paul Rocchi as the first NHT-funded PhD student	09/11/22

Directores	Puesto	Edad	Desde
Vincent Carrère CEO	Chief Executive Officer	-	-
Géraldine Le Duc FOU	Founder	-	11/12/15
Caroline Cayre DFI	Director of Finance/CFO	-	01/08/19

Administradores	Puesto	Edad	Desde
Philippe Archinard BRD	Director/Board Member	63	22/02/19
Marc Le Bozec BRD	Director/Board Member	-	22/02/19
Hervé Eloi Dominique Brailly CHM	Chairman	62	22/02/19